Schedule 13D ownership disclosure

Viking Therapeutics Inc

Security class unavailable · CUSIP: 92686J106

Event date: 2023-03-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-085535
Form type
SC 13D/A
Filer
LIGAND PHARMACEUTICALS INC
CIK
CIK 886163
Filed
Mar 30, 2023
Reporting period
Mar 28, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub